BeStock  
Markets › Compare › OLMA vs NVCT

OLMA vs NVCT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
OLMA · Olema Pharmaceuticals$7.02 ▼ 1.82%
NVCT · Nuvectis Pharma$19.39 ▼ 2.27%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

-1125251377503Nov 24, '25May 26, '26Nov 20, '26
  • OLMA -72.0%
  • NVCT +223.7%

Head to head

MetricOLMANVCT
Price$7.02$19.39
Change today▼ 1.82%▼ 2.27%
Market cap$615.00M$666.80M
Return, 3 months-32.7%-18.8%
Return, year to date-71.9%+156.8%
Return, 1 year-69.7%+218.9%
P/E (TTM)––
P/B1.75.3
P/E percentile vs own 5y54th22nd
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-74.3%-303.0%
Gross margin––
Operating margin––
Net margin––
Return on equity-69.8%-67.0%
Analyst target vs. price+360.5%+77.9%
Analyst buy share100%100%
RSI (14)4447
30-day volatility79.6%78.4%
Max drawdown, 1 year-82.1%-37.7%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NVCT is the largest of the group by market value.
  • NVCT has returned the most over the past year.
  • NVCT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top